Menu

UnitedHealth

NYSE: UNH

UnitedHealth Group is a leading American healthcare company operating through two major businesses: UnitedHealthcare, which provides health insurance and medical benefit plans for individuals, employers and government programmes, and Optum, which delivers healthcare services, pharmacy benefits, data analytics and technology solutions. UnitedHealthcare is its health insurance business, while Optum is the part driving its healthcare services, pharmacy and technology operations.

Sector
Health Services
Industry
Managed Health Care
Employees
390,000

The forecast figures are tipranks’s, read on 2026-11-16 and linked below.
The company facts and financials are CNN Business’s, read on 2026-11-16 and linked below.

UnitedHealth forecast

The forecast in short

tipranks records 17 analyst ratings on UnitedHealth and summarises them as “Strong Buy”. Their average 12-month price target is USD 482.69 (18.46% Upside). Its tipranks score is 7 out of 10 — Neutral. These are tipranks’s figures as read on 2026-11-16, not CariBroker’s own view, and nothing here is advice to buy or sell.

Market cap

USD 313.53 B

≈ RM 1.28 T

Share price

USD 349.91

≈ RM 1431.34 · 18 Nov close

#39World ranking

tipranks score

Neutral

7

Analyst ratings

Strong Buy

  • Buy1482%
  • Hold318%
  • Sell00%

tipranks’s own summary of the 17 ratings above.

12 months price forecast

USD 482.69 18.46% Upside

USD 241.05USD 346.49USD 451.92USD 557.36Past 12 months12 months forecastHighUSD 531AverageUSD 482.69LowUSD 4022025-112026-11

As tipranks publishes it. CariBroker has not recalculated any of it.

Financials

Q3 earnings, quarter ending Sep 29, 2026

MeasureQ3 20261-year change
Total revenue112.69B0.46% down
Net income4.11B41000.00% up
Earnings per share4.5676.21% up
Net profit margin3.65%75.77% up
Free cash flow4.26B2565.00% up
Debt-to-equity ratio0.769.43% down

Revenue and net income, last 4 quarters

$0.0$25.0B$50.0B$75.0B$100.0B$125.0BQ4 2025Q1 2026Q2 2026Q3 2026

Total revenueNet income

Analyst profiles: who made each call, and when

AnalystFromPositionTarget priceDated
Elizabeth Anderson CFAEvercore ISIBuyUSD 4802026-11-10
Lance WilkesBernsteinBuyUSD 5002026-11-04
Stephen BaxterWells FargoBuyUSD 4872026-10-27
Erin WrightMorgan StanleyBuyUSD 5312026-10-27
Ann HynesMizuho SecuritiesBuyUSD 5002026-10-22
Show all 25
AnalystFromPositionTarget priceDated
Ben HendrixRBC CapitalBuyUSD 4982026-10-19
Lisa GillJ.P. MorganBuyUSD 5242026-10-16
Whit MayoLeerink PartnersBuyUSD 4722026-10-15
Ryan LangstonTD CowenHoldUSD 4022026-10-15
Parker SnureRaymond JamesBuyUSD 4502026-10-15
Andrew Mok CFABarclaysBuyUSD 4402026-10-14
Kevin FischbeckBank of America SecuritiesBuyUSD 5122026-10-14
Jessica TassanPiper SandlerBuyUSD 5042026-10-14
Michael HaRobert W. BairdHoldUSD 4272026-10-14
Scott FidelGoldman SachsBuyUSD 5062026-10-13
A.J. RiceUBSBuyUSD 4902026-10-12
Hans EngelErste GroupHoldN/A2026-10-08
George HillDeutsche BankHoldN/A2026-08-03
David S MacdonaldTruist FinancialBuyUSD 5002026-07-17
Michael WiederhornOppenheimerBuyUSD 5002026-07-17
David ToungArgus ResearchBuyUSD 4702026-07-17
Matthew Gillmor CFAKeyBancBuyUSD 4752026-07-14
Sidharth SahooHSBCHoldUSD 3802026-07-06
David WindleyJefferiesBuyUSD 3732026-04-20
Sarah JamesCantor FitzgeraldBuyUSD 4402026-01-28

Investment strengths

Strong cash generation

UnitedHealth’s substantial operating and free cash flow supports investment across insurance, pharmacy, care delivery, and technology services while funding dividends and other capital needs. Free cash flow has also generally tracked earnings well, indicating meaningful underlying cash conversion despite recent growth volatility.

Diversified healthcare platform

The combination of UnitedHealthcare and Optum gives UnitedHealth multiple revenue streams across the healthcare value chain, reducing reliance on any single product or customer category. Its scale across benefits, pharmacy, care, and data services can support cross-segment capabilities and sustained relevance.

Medicare and Optum improvement

Improving Medicare margins and Optum Health’s large patient base provide identifiable avenues for earnings recovery and expansion. Progress toward the stated Optum margin range, together with value-based care and post-acute opportunities, could strengthen profitability over multiple quarters.

People also ask

What is the 12-month price target for UnitedHealth (UNH)?

tipranks publishes an average 12-month price target of USD 482.69 (18.46% Upside), as read on 2026-11-16. The highest target is USD 531 and the lowest is USD 402. A price target is an analyst’s estimate of where a share might trade, not a promise, and CariBroker gives no investment advice.

See tipranks’s own page ↗

How many analysts cover UnitedHealth (UNH)?

tipranks records 17 analyst ratings: 14 buy, 3 hold and 0 sell, which it summarises as “Strong Buy”, as read on 2026-11-16.

See tipranks’s own page ↗

What is the tipranks score for UnitedHealth (UNH)?

tipranks scores it 7 out of 10 and calls that “Neutral”, as read on 2026-11-16. The score is tipranks’s, not CariBroker’s, and CariBroker does not rate listed shares.

See tipranks’s own page ↗

Is this CariBroker’s own forecast for UnitedHealth?

No. Every figure on this page is published by tipranks, copied on 2026-11-16 with a link to the original, and not recalculated. CariBroker checks financial companies in Malaysia against the public registers; it makes no forecast of its own and holds no licence to advise on securities.

See tipranks’s own page ↗

Disclaimer

CariBroker provides information only and does not provide investment, financial or legal advice.

All investment ideas

Check another company

Search every bank, broker and alert list in one place